Pulse Biosciences (PLSE) Beginning Cash Balance (2023)
Pulse Biosciences' quarterly Beginning Cash Balance came in at $828000.0 in Q2 2023, down 9.71% quarter-over-quarter from $917000.0 in Q1 2023.
Pulse Biosciences has reported Beginning Cash Balance for 1 years, with the latest figure at $828000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Pulse Biosciences | 1.72 Bn | 1.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 828,000.00 |
| Jun 30, 2023 | 828,000.00 |
| Mar 31, 2023 | 917,000.00 |
| Mar 31, 2023 | 917,000.00 |